These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 15856315

  • 1. Comparison of 1-84 and intact parathyroid hormone assay in pediatric dialysis patients.
    Sheth RD, Goldstein SL.
    Pediatr Nephrol; 2005 Jul; 20(7):977-81. PubMed ID: 15856315
    [Abstract] [Full Text] [Related]

  • 2. Variable parathyroid hormone(1-84)/carboxylterminal PTH ratios detected by 4 novel parathyroid hormone assays.
    Koller H, Zitt E, Staudacher G, Neyer U, Mayer G, Rosenkranz AR.
    Clin Nephrol; 2004 May; 61(5):337-43. PubMed ID: 15182128
    [Abstract] [Full Text] [Related]

  • 3. Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal disease patients: implication for treatment decisions.
    Cantor T, Yang Z, Caraiani N, Ilamathi E.
    Clin Chem; 2006 Sep; 52(9):1771-6. PubMed ID: 16858070
    [Abstract] [Full Text] [Related]

  • 4. Influence of PTH assay methodology on differential diagnosis of renal bone disease.
    Reichel H, Esser A, Roth HJ, Schmidt-Gayk H.
    Nephrol Dial Transplant; 2003 Apr; 18(4):759-68. PubMed ID: 12637646
    [Abstract] [Full Text] [Related]

  • 5. The assay of the hypocalcemic PTH fragment inhibitor with PTH provides a more accurate assessment of renal osteodystrophy compared to the intact PTH assay.
    Cantor T, Sci B.
    Nefrologia; 2003 Apr; 23 Suppl 2():69-72. PubMed ID: 12778858
    [Abstract] [Full Text] [Related]

  • 6. Bio-intact parathyroid hormone and intact parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism receiving intravenous calcitriol therapy.
    Fujimori A, Sakai M, Yoshiya K, Shin J, Kim JI, Inaba Y, Miyamoto T, Inoue S, Fukagawa M.
    Ther Apher Dial; 2004 Dec; 8(6):474-9. PubMed ID: 15663547
    [Abstract] [Full Text] [Related]

  • 7. Significance of Bio-intact PTH(1-84) assay in hemodialysis patients.
    Inaba M, Okuno S, Imanishi Y, Ueda M, Yamakawa T, Ishimura E, Nishizawa Y.
    Osteoporos Int; 2005 May; 16(5):517-25. PubMed ID: 15322741
    [Abstract] [Full Text] [Related]

  • 8. Parathyroid hormone assays--evolution and revolutions in the care of dialysis patients.
    Malluche HH, Mawad H, Trueba D, Monier-Faugere MC.
    Clin Nephrol; 2003 May; 59(5):313-8. PubMed ID: 12779091
    [Abstract] [Full Text] [Related]

  • 9. PTH 1-84 and PTH "7-84" in the noninvasive diagnosis of renal bone disease.
    Coen G, Bonucci E, Ballanti P, Balducci A, Calabria S, Nicolai GA, Fischer MS, Lifrieri F, Manni M, Morosetti M, Moscaritolo E, Sardella D.
    Am J Kidney Dis; 2002 Aug; 40(2):348-54. PubMed ID: 12148108
    [Abstract] [Full Text] [Related]

  • 10. Differences between "intact" PTH and 1-84 PTH assays in chronic renal failure and dialysis.
    Waller S, Ridout D, Cantor T, Rees L.
    Pediatr Nephrol; 2005 Feb; 20(2):197-9. PubMed ID: 15627166
    [Abstract] [Full Text] [Related]

  • 11. Changes in total parathyroid hormone (PTH), PTH-(1-84) and large C-PTH fragments in different stages of chronic kidney disease.
    Herberth J, Fahrleitner-Pammer A, Obermayer-Pietsch B, Krisper P, Holzer H, Malluche HH, Dobnig H.
    Clin Nephrol; 2006 May; 65(5):328-34. PubMed ID: 16724653
    [Abstract] [Full Text] [Related]

  • 12. Measurement of PTH fragments for assessment of renal bone disease in hemodialysis patients.
    Fehr T, Garzoni D, Staub T, Binet I, Wüthrich RP.
    Kidney Blood Press Res; 2006 May; 29(3):175-81. PubMed ID: 16931896
    [Abstract] [Full Text] [Related]

  • 13. Effect of haemodialysis on markers of bone turnover in children.
    Waller S, Ridout D, Rees L.
    Pediatr Nephrol; 2007 Apr; 22(4):586-92. PubMed ID: 17216258
    [Abstract] [Full Text] [Related]

  • 14. Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis.
    Salusky IB, Goodman WG, Kuizon BD, Lavigne JR, Zahranik RJ, Gales B, Wang HJ, Elashoff RM, Jüppner H.
    Kidney Int; 2003 May; 63(5):1801-8. PubMed ID: 12675856
    [Abstract] [Full Text] [Related]

  • 15. Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry.
    Lehmann G, Stein G, Hüller M, Schemer R, Ramakrishnan K, Goodman WG.
    Kidney Int; 2005 Sep; 68(3):1206-14. PubMed ID: 16105052
    [Abstract] [Full Text] [Related]

  • 16. 7-84 parathyroid hormone fragments are proportionally increased with the severity of uremic hyperparathyroidism.
    Chang JM, Lin SP, Kuo HT, Tsai JC, Tomino Y, Lai YH, Chen HC.
    Clin Nephrol; 2005 May; 63(5):351-5. PubMed ID: 15909594
    [Abstract] [Full Text] [Related]

  • 17. Two-site immunoradiometric intact parathyroid hormone assay versus C-terminal parathyroid hormone in predicting osteodystrophic bone lesions in predialysis chronic renal failure.
    Coen G, Mazzaferro S, Ballanti P, Bonucci E, Cinotti GA, Fondi G, Manni M, Pasquali M, Perruzza I, Sardella D.
    J Lab Clin Med; 1993 Jul; 122(1):103-9. PubMed ID: 8320484
    [Abstract] [Full Text] [Related]

  • 18. Switching between parathormone (PTH) assays: the impact on the diagnosis of renal osteodystrophy.
    Bekő G, Butz H, Berta K, Tislér A, Olajos F, Vásárhelyi B, Patócs A.
    Clin Chem Lab Med; 2013 Jun; 51(6):1251-6. PubMed ID: 23241601
    [Abstract] [Full Text] [Related]

  • 19. Comparison between whole and intact parathyroid hormone assays.
    Taniguchi M, Tanaka M, Hamano T, Nakanishi S, Fujii H, Kato H, Koiwa F, Ando R, Kimata N, Akiba T, Kono T, Yokoyama K, Shigematsu T, Kakuta T, Kazama JJ, Tominaga Y, Fukagawa M.
    Ther Apher Dial; 2011 Jun; 15 Suppl 1():42-9. PubMed ID: 21595852
    [Abstract] [Full Text] [Related]

  • 20. [Diagnostic accuracy study comparing total alkaline phosphatase with intact parathyroid hormone 1-84 for the diagnosis of high turnover renal osteodystrophy in chronic renal failure on hemodialysis].
    Rojas González AM, Opazo Valenzuela M, Muñoz Navarro S.
    Medwave; 2014 Sep 03; 14(8):e6014. PubMed ID: 25340338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.